Cubist Systematic Strategies’s Maravai LifeSciences MRVI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-284,146
| Closed | -$2.03M | – | 1977 |
|
|
2024
Q2 | $2.03M | Sell |
284,146
-75,957
| -21% | -$544K | 0.01% | 576 |
|
|
2024
Q1 | $3.12M | Buy |
360,103
+247,707
| +220% | +$2.15M | 0.02% | 696 |
|
|
2023
Q4 | $736K | Buy |
+112,396
| New | +$736K | ﹤0.01% | 1247 |
|
|
2023
Q3 | – | Sell |
-6,618
| Closed | -$82.3K | – | 2369 |
|
|
2023
Q2 | $82.3K | Sell |
6,618
-163,371
| -96% | -$2.03M | ﹤0.01% | 1849 |
|
|
2023
Q1 | $2.38M | Sell |
169,989
-126,750
| -43% | -$1.78M | 0.01% | 1022 |
|
|
2022
Q4 | $4.25M | Buy |
296,739
+294,199
| +11,583% | +$4.21M | 0.02% | 787 |
|
|
2022
Q3 | $65K | Sell |
2,540
-202,385
| -99% | -$5.18M | ﹤0.01% | 3294 |
|
|
2022
Q2 | $5.82M | Buy |
204,925
+21,187
| +12% | +$602K | 0.04% | 698 |
|
|
2022
Q1 | $6.48M | Buy |
183,738
+99,047
| +117% | +$3.49M | 0.05% | 535 |
|
|
2021
Q4 | $3.55M | Sell |
84,691
-36,267
| -30% | -$1.52M | 0.03% | 891 |
|
|
2021
Q3 | $5.94M | Buy |
120,958
+25,662
| +27% | +$1.26M | 0.07% | 382 |
|
|
2021
Q2 | $3.98M | Buy |
95,296
+31,902
| +50% | +$1.33M | 0.04% | 670 |
|
|
2021
Q1 | $2.26M | Sell |
63,394
-14,395
| -19% | -$513K | 0.03% | 943 |
|
|
2020
Q4 | $2.18M | Buy |
+77,789
| New | +$2.18M | 0.03% | 889 |
|